Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Chetou Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs), chemical intermediates, and finished dosage forms. Founded in 1988 and headquartered in Linhai, Zhejiang, the company has established itself as a global leader in the production of non-steroidal anti-inflammatory drugs (NSAIDs) and antiviral medications. Its core product portfolio includes high-demand substances such as naproxen, acyclovir, and entecavir, which are exported to major regulated markets including the United States, the European Union, and Japan. The company operates multiple state-of-the-art manufacturing facilities that are GMP-certified by international regulatory authorities like the FDA and EMA. In addition to its generic drug business, Chetou Pharma provides comprehensive CDMO services to global pharmaceutical partners, leveraging its expertise in complex chemical synthesis and process optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 浙江车头制药.